Recent Updates
Recently added Catalysts
PHG Positive Sentiment

Riassunto: Philips e Imricor lanciano una soluzione per laboratorio di risonanza magnetica interventistica cardiaca, ampliando la loro collaborazione di lunga data

Key Takeaway: Philips and Imricor have announced a new interventional MRI lab solution for Philips 1.5T MR. This marks an expansion of their long-standing collaboration, enhancing capabilities in MRI-compatible products for interventional procedures. The new solution is the first of its kind available commercially, showcasing innovation in healthcare technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of a new MRI interventional lab solution.
  • Collaboration between Philips and Imricor is expanding.
  • Philips is a leader in healthcare technology.

Full Press Release Details

AMSTERDAM--(BUSINESS WIRE)--Royal Philips (NYSE: PHG, AEX: PHIA), leader globale nella tecnologia sanitaria, e Imricor Medical Systems (ASX: IMR), un pioniere e sviluppatore leader mondiale di prodotti compatibili con la risonanza magnetica per procedure di RM interventistica, hanno annunciato oggi una nuova soluzione da laboratorio per risonanza magnetica interventistica (iRM) per Philips 1.5T MR. La prima configurazione* disponibile in commercio integra la piattaforma 1.5T MRI di Philips e il

Frequently Asked Questions

What is the new solution launched by Philips and Imricor?

Philips and Imricor launched a new interventional MRI lab solution for Philips 1.5T MR.

What does the new MRI solution integrate?

The solution integrates the Philips 1.5T MRI platform with Imricor's technology.

What is the significance of this launch?

This launch expands the long-standing collaboration between Philips and Imricor.

Who are the key players in this collaboration?

The key players are Royal Philips and Imricor Medical Systems.

Last updated: Aug 28, 2026